Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma

Fig. 2

RBM10 was downregulated in CCA. A The different levels of RBM10 mRNA expression in paired CCA and adjacent tissues (n = 64). B The individual RBM10 mRNA expression difference distribution between tumor and para-tumor. C Representative IHC stains of RBM10 in CCA and adjacent normal tissues. D, E The prognostic value of RBM10 expression in CCA was evaluated by Kaplan-Meier analysis of overall survival (OS) and recurrence-free survival (RFS) according to the IHC staining intensity of RBM10 in TMA (n = 177). Blue line, high RBM10 expression in CCA; red line, low RBM10 expression in CCA

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us